SUBSCRIBE
SUBSCRIBE

Nimble Therapeutics

IN THE PRESS
Pharm Country
Nimble Therapeutics Expands its Drug Discovery Capabilities to Advance Pipeline to the Clinic
April 3, 2024
 · 
4 min read
BioMidwest
Nimble Therapeutics Adds Peptide Drug Development Expertise to Board of Directors
March 19, 2024
 · 
3 min read
BioMidwest
Nimble Therapeutics Announces Expansion of its Discovery and Development Partnership with Genentech
January 5, 2023
 · 
2 min read
BioMidwest
Nimble Therapeutics Delivers Lead Compounds for Two Programs Under Collaboration with Large Pharma Partner, Triggering Milestone Payments
December 13, 2022
 · 
2 min read
Business
Nimble Therapeutics names Pete Gough as Chief Scientific Officer
November 30, 2022
 · 
3 min read
BioMidwest
Nimble Therapeutics Announces Achievement of Development Milestones From Multiple Partnered Programs Connected to a Strategic Large Pharma Collaboration
May 17, 2022
 · 
1 min read
Business
Nimble Therapeutics and Incyte Expand their Strategic Research Collaboration to Discover Additional Novel Peptide Therapeutics
September 14, 2021
 · 
1 min read
Business
Nimble Therapeutics Appoints Cyrus Arman, PhD, MBA as Chief Business Officer
September 8, 2021
 · 
2 min read
Business
Nimble Therapeutics and RayzeBio Announce Strategic Research Collaboration to Discover & Develop Novel Peptide-Based Radiopharmaceuticals
June 28, 2021
 · 
2 min read
Business
Nimble Announces Strategic Research Collaboration with Incyte to Discover Novel Peptide-Based Therapeutics
October 5, 2020
 · 
1 min read
JOBS